Makio Ogawa to Graft Survival
This is a "connection" page, showing publications Makio Ogawa has written about Graft Survival.
Connection Strength
0.776
-
An efficient method for single hematopoietic stem cell engraftment in mice based on cell-cycle dormancy of hematopoietic stem cells. Exp Hematol. 2010 Jul; 38(7):603-8.
Score: 0.276
-
An assay for human hematopoietic stem cells based on transplantation into nonobese diabetic recombination activating gene-null perforin-null mice. Biol Blood Marrow Transplant. 2005 Jul; 11(7):487-94.
Score: 0.199
-
An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/beta2-microglobulin(null) mice. Exp Hematol. 2002 May; 30(5):488-94.
Score: 0.160
-
Human cord blood long-term engrafting cells are CD34+ CD38-. Leukemia. 2003 May; 17(5):960-4.
Score: 0.043
-
Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999 Oct 15; 94(8):2548-54.
Score: 0.033
-
Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: transduction of the negative signals by betac and betaIL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor. Blood. 1998 Aug 01; 92(3):901-7.
Score: 0.031
-
CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood. 1996 May 15; 87(10):4136-42.
Score: 0.026
-
Engraftment of cultured human hematopoietic cells in sheep. Blood. 1998 May 15; 91(10):3688-92.
Score: 0.008